Skip to main content
Clinical Trials/NCT03324464
NCT03324464CompletedNot Applicable

Central Executive Training for ADHD: Efficacy Trial

Florida State University1 site in 1 country251 target enrollmentStarted: January 1, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
251
Locations
1
Primary Endpoint
ADHD symptoms

Study Overview

Brief Summary

The goal of the current project is to assess the efficacy of Central Executive Training (CET) for youth with ADHD. CET is a new, computerized training intervention that targets specific components of the working memory system. Two versions of CET were developed as part of our R34, each targeting a different combinations of executive functions. The final CET protocol reflects the contributions and feedback of a diverse group of caregivers, children with ADHD, and recognized experts in human cognition, ADHD treatment research, randomized control trial (RCT) intervention design methods, serious game theory and task design, cognitive training, and the role of executive dysfunction in ADHD.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Eligibility Criteria

Ages
8 Years to 12 Years (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Children ages 8-12 with principal ADHD diagnoses (via Kiddie Schedule for Affective Disorders semi-structured clinical interviewing (K-SADS)
  • •Parent AND teacher ratings in clinical/borderline range based on age and gender on ADHD-RS-5 or BASC-3 Attention Problems/Hyperactivity subscales
  • •Below average or lower working memory on at least one pre-treatment WM test. All ADHD presentations will be eligible.

Exclusion Criteria

  • •gross neurological, sensory, or motor impairment
  • •history of seizure disorder, psychosis, bipolar, or severe dysregulation disorders that may interfere with study participation (substance use, disruptive mood dysregulation, intermittent explosive, reactive attachment)
  • •intellectual disability or Wechsler Intelligence Scale for Children (WISC-V) short-form intelligence quotient (FSIQ) < 78 (1.5 standard deviations (SD) below mean)
  • •conditions requiring acute intervention, e.g., active suicidality
  • •non-English speaking child or parent.

Arms & Interventions

CET-Working Memory (WM)

Experimental

Central Executive Training: Working Memory

Intervention: Central Executive Training: Working Memory (Behavioral)

CET-Behavioral Inhibition (BI)

Active Comparator

Central Executive Training: Inhibitory Control

Intervention: Central Executive Training: Inhibitory Control (Behavioral)

Outcomes

Primary Outcomes

ADHD symptoms

Time Frame: Immediate post-treatment (within 2 weeks of final treatment session)

Average of T-scores on parent-report ADHD symptoms questionnaires (Attention Deficit Hyperactivity Disorder Rating Scale (ADHD-5) Inattention and Hyperactivity subscales, Behavioral Assessment System for Children (BASC-3) Inattention and Hyperactivity subscales)

Secondary Outcomes

  • Inhibitory control(Immediate post-treatment (within 2 weeks of final treatment session))
  • Actigraph-measured hyperactivity during working memory testing(Immediate post-treatment (within 2 weeks of final treatment session))
  • Working Memory(Immediate post-treatment (within 2 weeks of final treatment session))
  • Actigraph-measured hyperactivity during baseline(Immediate post-treatment (within 2 weeks of final treatment session))

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Michael J. Kofler

Associate Professor

Florida State University

Study Sites (1)

Loading locations...

Similar Trials